1887
  1. Home
  2. Eurosurveillance
  3. Volume 26, Issue 16, 22/Apr/2021
  4. Article
Rapid communication Open Access
Like 1
Download

Abstract

We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0–2.9; B.1.351: 3.6, 95% CI: 2.1–6.2; P.1: 2.6, 95% CI: 1.4–4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4–3.5; P.1: 2.2, 95% CI: 1.7–2.8).

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.16.2100348
2021-04-22
2024-04-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2021.26.16.2100348
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/16/eurosurv-26-16-1.html?itemId=/content/10.2807/1560-7917.ES.2021.26.16.2100348&mimeType=html&fmt=ahah

References

  1. Public Health England (PHE). Investigation of novel SARS-CoV-2 variant - variant of concern 202012/01. London: PHE; 2020. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/959438/Technical_Briefing_VOC_SH_NJL2_SH2.pdf
  2. European Centre for Disease Prevention and Control (ECDC). Risk assessment: Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-spread-new-variants-concern-eueea-first-update
  3. Japanese National Institute of Infectious Diseases (NIID). Brief report: new variant strain of SARS-CoV-2 identified in travelers from Brazil: Tokyo: NIID; 2021. Available from: https://www.niid.go.jp/niid/en/2019-ncov-e/10108-covid19-33-en.html
  4. Faria NR, Claro IM, Candido D, Franco LAM, Andrade PS, Coletti TM, et al. Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings. Virological.org. 2021. Available from: https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586
  5. Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. 2020:2020.12.21.20248640.  https://doi.org/10.1101/2020.12.21.20248640 
  6. European Centre for Disease Prevention and Control (ECDC). COVID-19 country overviews, week 12/2021, 1 April 2021. Stockholm: ECDC; 2021. Available from: https://covid19-surveillance-report.ecdc.europa.eu/archive-COVID19-reports/archive/2021W12_country_overview_report_20210331.zip
  7. Horby P, Huntley C, Davies N, Edmunds J, Ferguson N, Medley G, et al. NERVTAG note on B.1.1.7 severity. London: Government Digital Service; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/955239/NERVTAG_paper_on_variant_of_concern__VOC__B.1.1.7.pdf
  8. Bager P, Wohlfahrt J, Fonager J, Rasmussen M, Albertsen M, Yssing Michaelsen T, et al. Increased risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark. Preprints with the Lancet. 2021. Available from: https://ssrn.com/abstract=3792894 or http://dx.doi.org/ https://doi.org/10.2139/ssrn.3792894 
  9. Davies NG, Jarvis CI, Edmunds WJ, Jewell NP, CMMID COVID-19 Working Group, Diaz-Ordaz K, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021.  https://doi.org/10.1038/s41586-021-03426-1  PMID: 33723411 
  10. Challen R, Brooks-Pollock E, Read JM, Dyson L, Tsaneva-Atanasova K, Danon L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ. 2021;372(579):n579.  https://doi.org/10.1136/bmj.n579  PMID: 33687922 
  11. Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021;NEJMoa2102214.  https://doi.org/10.1056/NEJMoa2102214  PMID: 33725432 
  12. Wang P, Liu L, Iketani S, Luo Y, Guo Y, Wang M, et al. Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization. bioRxiv. 2021:2021.01.25.428137.  https://doi.org/10.1101/2021.01.25.428137 
  13. Novel variant incident management team, Public Health England with Imperial College, the University of Edinburgh, the University of Birmingham and the Wellcome Sanger Institute. New evidence on VUI-202012/01 and review of the public health risk assessment. London: Public Health England; 2020. Available from: https://khub.net/documents/135939561/338928724/New+SARS-COV-2+variant+-+information+and+risk+assessment.pdf/b56d4591-0466-1a18-28dc-010e0fdeef53?t=1608569319930
  14. Public Health England (PHE). Investigation of SARS-CoV-2 variants of concern in England. London: PHE; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/961299/Variants_of_Concern_VOC_Technical_Briefing_6_England-1.pdf
  15. Borges V, Sousa C, Menezes L, Gonçalves AM, Picão M, Almeida JP, et al. Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021. Euro Surveill. 2021;26(10):2100131.  https://doi.org/10.2807/1560-7917.ES.2021.26.10.2100130  PMID: 33706862 
  16. Robert Koch-Institut (RKI). Risikobewertung zu COVID-19. [Risk assessment of COVID-19]. Berlin: RKI; 2021. German. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Risikobewertung.html
  17. European Centre for Disease Prevention and Control (ECDC), World Health Organization Regional Office for Europe (WHO/Europe). Methods for the detection and identification of SARS-CoV-2 variants. Stockholm and Copenhagen: ECDC and WHO/Europe; 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Methods-for-the-detection-and-identification-of-SARS-CoV-2-variants-WHO-ECDC.pdf
  18. European Centre for Disease Prevention and Control (ECDC). Risk related to spread of new SARSCoV-2 variants of concern in the EU/EEA - 29 December 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-risk-related-to-spread-of-new-SARS-CoV-2-variants-EU-EEA.pdf
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Tjede+Funk&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Funk Tjede</a>, <a href="/search?value1=Anastasia+Pharris&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pharris Anastasia</a>, <a href="/search?value1=Gianfranco+Spiteri&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Spiteri Gianfranco</a>, <a href="/search?value1=Nick+Bundle&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bundle Nick</a>, <a href="/search?value1=Angeliki+Melidou&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Melidou Angeliki</a>, <a href="/search?value1=Michael+Carr&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Carr Michael</a>, <a href="/search?value1=Gabriel+Gonzalez&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gonzalez Gabriel</a>, <a href="/search?value1=Alejandro+Garcia-Leon&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Garcia-Leon Alejandro</a>, <a href="/search?value1=Fiona+Crispie&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Crispie Fiona</a>, <a href="/search?value1=Lois+O%E2%80%99Connor&option1=author&noRedirect=true" class="nonDisambigAuthorLink">O’Connor Lois</a>, <a href="/search?value1=Niamh+Murphy&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Murphy Niamh</a>, <a href="/search?value1=Jo%C3%ABl+Mossong&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mossong Joël</a>, <a href="/search?value1=Anne+Vergison&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vergison Anne</a>, <a href="/search?value1=Anke+K.+Wienecke-Baldacchino&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Wienecke-Baldacchino Anke K.</a>, <a href="/search?value1=Tamir+Abdelrahman&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Abdelrahman Tamir</a>, <a href="/search?value1=Flavia+Riccardo&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Riccardo Flavia</a>, <a href="/search?value1=Paola+Stefanelli&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stefanelli Paola</a>, <a href="/search?value1=Angela+Di+Martino&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Di Martino Angela</a>, <a href="/search?value1=Antonino+Bella&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bella Antonino</a>, <a href="/search?value1=Alessandra+Lo+Presti&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lo Presti Alessandra</a>, <a href="/search?value1=Pedro+Casaca&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Casaca Pedro</a>, <a href="/search?value1=Joana+Moreno&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Moreno Joana</a>, <a href="/search?value1=V%C3%ADtor+Borges&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Borges Vítor</a>, <a href="/search?value1=Joana+Isidro&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Isidro Joana</a>, <a href="/search?value1=Rita+Ferreira&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ferreira Rita</a>, <a href="/search?value1=Jo%C3%A3o+Paulo+Gomes&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gomes João Paulo</a>, <a href="/search?value1=Liidia+Dotsenko&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Dotsenko Liidia</a>, <a href="/search?value1=Heleene+Suija&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Suija Heleene</a>, <a href="/search?value1=Jevgenia+Epstein&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Epstein Jevgenia</a>, <a href="/search?value1=Olga+Sadikova&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sadikova Olga</a>, <a href="/search?value1=Hanna+Sepp&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sepp Hanna</a>, <a href="/search?value1=Niina+Ikonen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ikonen Niina</a>, <a href="/search?value1=Carita+Savolainen-Kopra&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Savolainen-Kopra Carita</a>, <a href="/search?value1=Soile+Blomqvist&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Blomqvist Soile</a>, <a href="/search?value1=Teemu+M%C3%B6tt%C3%B6nen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Möttönen Teemu</a>, <a href="/search?value1=Otto+Helve&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Helve Otto</a>, <a href="/search?value1=Joana+Gomes-Dias&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gomes-Dias Joana</a>, <a href="/search?value1=Cornelia+Adlhoch&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Adlhoch Cornelia</a>, <a href="/search?value1=on+behalf+of+COVID+study+groups&option1=author&noRedirect=true" class="nonDisambigAuthorLink">on behalf of COVID study groups</a></span>. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. <a href="/content/ecdc">Euro Surveill.</a> 2021;26(16):pii=2100348. <a href="https://doi.org/10.2807/1560-7917.ES.2021.26.16.2100348" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2021.26.16.2100348</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 23 Mar 2021;&nbsp;&nbsp; <span class="generated">Accepted</span>: 21 Apr 2021 </span> </p>
/content/10.2807/1560-7917.ES.2021.26.16.2100348
/content/10.2807/1560-7917.ES.2021.26.16.2100348
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error